Joel Isaacson & Co., LLC
Source: SEC Form 13F · as of Mar 2026Joel Isaacson & Co., LLC holds 26 biotech & pharma companies tracked by BioSniper, totaling $63.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$63.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 79,358 | $19.4M |
| LLYELI LILLY & Co | 11,707 | $10.8M |
| CORCencora Inc. | 22,815 | $7.2M |
| MRKMerck & Co., Inc. | 43,512 | $5.2M |
| AMGNAMGEN INC | 8,056 | $2.8M |
| PFEPFIZER INC | 84,645 | $2.4M |
| REGNREGENERON PHARMACEUTICALS, INC. | 3,067 | $2.4M |
| BMYBRISTOL MYERS SQUIBB CO | 38,011 | $2.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,396 | $2.0M |
| ABBVAbbVie Inc. | 8,193 | $1.8M |
| PMPhilip Morris International Inc | 8,862 | $1.5M |
| NVSNovartis AG | 6,486 | $991K |
| NVONovo Nordisk A/S | 21,026 | $773K |
| ELVElevance Health Inc. | 2,458 | $720K |
| HALOHALOZYME THERAPEUTICS, INC. | 10,247 | $662K |
| ABTABBOTT LABORATORIES | 4,950 | $508K |
| AZNASTRAZENECA PLC | 2,413 | $476K |
| IDXXIDEXX LABORATORIES INC /DE | 698 | $392K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 5,458 | $301K |
| BIIBBIOGEN INC. | 1,614 | $296K |
| GILDGILEAD SCIENCES, INC. | 1,758 | $245K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 506 | $226K |
| IBRXImmunityBio, Inc. | 25,000 | $192K |
| EDITEditas Medicine, Inc. | 68,144 | $168K |
| VTRSViatris Inc | 10,114 | $137K |
| CGENCOMPUGEN LTD | 12,000 | $26K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.